// App-Quantinova.ai

3912 : MM-310, a novel EphA2-targeted docetaxel nanoliposome

Researchers

Presenter

  • Dmitri B. Kirpotin

Principal Investigators

  • Suresh Tipparaju

  • Zhaohua Richard Huang

  • Walid S. Kamoun

  • Christine Pien

  • Tad Kornaga

  • Shinji Oyama

  • Ken Olivier

  • James D. Marks

  • Alexander Koshkaryev

  • Sarah S. Schihl

  • Gerald Fetterly

  • Birgit Schoeberl

  • Charles Noble

  • Mark Hayes

  • Daryl C. Drummond

Medical Centers

  • Merrimack, Cambridge, MA

  • UCSF, San Francisco, CA

  • Roswell Park Cancer Institute, Buffalo, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • taxane

  • MM310

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved